Position in ACRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,283,454
+$2,552,612 QoQ
Shares Held
998,763
+37.2% QoQ
Ownership
0.679%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. ACRS ranks #160 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ACRS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,283,454 | 998,763 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $2,730,842 | 728,225 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,999,414 | 664,258 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,331,562 | 700,823 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,088,080 | 766,255 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $411,701 | 269,086 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $434,433 | 175,175 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $146,308 | 127,225 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $572,515 | 520,469 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $697,156 | 562,224 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $692,617 | 659,637 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,516,690 | 659,371 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,739,742 | 649,927 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,570,388 | 564,943 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,937,636 | 567,469 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,711,837 | 553,484 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,310,558 | 523,679 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,105,661 | 470,166 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,121,633 | 489,796 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $9,029,394 | 501,633 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,015,014 | 456,436 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,741,632 | 108,795 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $586,743 | 90,687 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $246,158 | 95,782 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $159,740 | 98,606 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $369,330 | 355,127 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||